David A. Eichenbaum, MD, FASRS, discusses findings on UBX-1325 for diabetic macular edema, highlighting a shift towards personalized, multi-mechanism therapies.
Dr David A. Eichenbaum
Advertisement
Articles by Dr David A. Eichenbaum
SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Revisiting an overlooked solution for high myopia
2
FLORetina 2025: Industry advances front and center at FLORetina Congress
3
The accessibility barriers still hindering ophthalmology
4
FLORetina Congress celebrates 10 years with joint World Retinopathy of Prematurity meeting
5
